reported that knocking down HMGB1 inhibited the growth and invasion of GC cells via the NF-κB pathway both in vitro and in vivo, indicating that HMGB1 may serve as a potential therapeutic target for gastric adenocarcinoma (GAC) (29). This evidence concerns the gene NFKB1 and gastric adenocarcinoma.